Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial. - Wikidata - awgldk - TriplyDB

Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial.

Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial.

http://www.wikidata.org/entity/Q39396121

about

Korean clinical practice guideline for benign prostatic hyperplasia A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.Long-term treatment with finasteride improves clinical progression of benign prostatic hyperplasia in men with an enlarged versus a smaller prostate: data from the MTOPS trial Prostatic fibrosis, lower urinary tract symptoms, and BPH Prostatic inflammation induces urinary frequency in adult mice Altering disease progression: the key to successful patient management.Changing patients' profile presenting for surgical management of benign prostatic hyperplasia over the past 16 years: A single-centre perspective CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion through Non-Canonical EGFR/MEK/ERK Signaling.Dutasteride: a dual 5-alpha reductase inhibitor for the treatment of symptomatic benign prostatic hyperplasia.Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.Therapeutic options in the treatment of benign prostatic hyperplasia.Evaluating racial/ethnic disparities in lower urinary tract symptoms in men.Does digital rectal examination predict prostate volume greater than 30 mL?Doxazosin-induced up-regulation of alpha 1A-adrenoceptor mRNA in the rat lower urinary tract.Cyclic guanosine monophosphate-enhancing reduces androgenic extracellular regulated protein kinases-phosphorylation/Rho kinase II-activation in benign prostate hyperplasia.Prevalence of low testosterone and its relationship to body mass index in older men with lower urinary tract symptoms associated with benign prostatic hyperplasia.Association of elevated interleukin-17 and angiopoietin-2 with prostate size in benign prostatic hyperplasia.

P2860

Q26766302-1FCD8BD3-51E4-4601-86CA-689ACB20F74F Q28295781-FCE000B4-D01B-43C1-BBD4-6052EC0C9909 Q30432603-45A4D66E-F8B7-4F8F-828E-3517F5834497 Q33741548-F914CF86-E7AF-40E7-BC4C-C1B22953FABF Q33824628-D9181B37-AA8A-4FC8-9735-C8002831EEFE Q34822091-DCD98355-9607-4274-9E8B-CA865514F2C4 Q35043971-E9B2C78F-5510-41B8-A1A9-5385ABC3B631 Q35685859-FE12AF7C-AC86-45E5-8E13-1BBB19BD07B4 Q35898649-F5AE9498-1F60-4A3B-9AD6-1E73A0B67465 Q36081785-A8302914-591A-4A94-BC73-7F537E7E56AD Q36434305-D40F9F08-F89E-4015-A42F-C90E9FD8272C Q37092262-3D2E76C4-C427-46FD-8DC2-06A603413F99 Q37107552-72C8A873-1D14-4E83-BC95-3CBDFE477AB0 Q37305883-BE4B54A1-029F-41BC-9243-2E9C1166975C Q37423744-B85F23CB-DDFB-4C1C-89C0-95B92EDFC5EC Q37733861-1504CECB-F20E-471B-A063-8A74F4DF51EA Q40452225-B67318FF-806A-4CC5-AA32-0D12E0F400F3 Q45169155-62029975-9C2A-40B5-A433-1DCA1A345B19 Q45286544-721AEA88-73B5-4D23-A249-6E6DBF0E9681 Q46309201-2A34C6FE-6414-482F-8412-E6BE1933334B Q47207790-B1EA671B-47E4-4833-99EA-EDBDC687C8DC

P2860

Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial.

http://www.wikidata.org/entity/Q39396121

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial.

@en

Study design of the Medical Therapy of Prostatic Symptoms

@nl

type

label

Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial.

@en

Study design of the Medical Therapy of Prostatic Symptoms

@nl

prefLabel

Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial.

@en

Study design of the Medical Therapy of Prostatic Symptoms

@nl

P1433

Q39396121-8CDE7D3D-5FCF-41F3-803E-317CFA22676F

P1476

Q39396121-7CD6C646-32FB-4041-94FE-C08C385D69F7

P2093

Q39396121-1683F8F1-9FD8-4856-9349-263478526A5A

Q39396121-25805B64-D9D1-46DB-A395-515788CBD816

Q39396121-40D44C0C-A8A4-4454-A823-3722CCE9669A

Q39396121-44F3F6FD-B2C8-49B4-B333-15D2A6E5BFB3

Q39396121-4A6BA9A5-8659-470D-87A3-1E6DBF5F2369

Q39396121-5B1AD10B-C4ED-48C0-A883-8F2BF70F3BC7

Q39396121-625420A8-7B8F-4C24-A675-C8F19E54D612

Q39396121-7956D1B8-49AA-4787-8EAF-44BD8163C53C

Q39396121-907DCF0C-A3E3-407B-B3E0-10895ADE0EE8

Q39396121-A6E95DEF-92EC-43CC-9692-A82FE7945EAA

P304

Q39396121-3F9BB72C-7200-4AA3-B580-C343160A6CAE

P31

Q39396121-5A1F9FDF-7535-475B-90ED-B30AA330F78C

P356

Q39396121-10A30E16-AEC0-440A-8111-B7307C3C4CEA

P407

Q39396121-3BB64857-C52E-4F90-97B7-0A04C8A7CE75

P433

Q39396121-270C8676-D865-4AE8-96DC-01C151926213

P478

Q39396121-03CE28E1-F18E-4A78-B690-5A0514DB14C0

P577

Q39396121-B8C5A013-4691-4AEE-8F1D-55A321A87790

P698

Q39396121-C395D1C8-B07F-407F-AA0A-6FC72B7D1969

P356

S0197-2456(02)00263-5

P1433

Contemporary Clinical Trials

P1476

Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial.

@en

P2093

E David Crawford

http://www.w3.org/2001/XMLSchema#string

Gary Miller

http://www.w3.org/2001/XMLSchema#string

Hebert Lepor

http://www.w3.org/2001/XMLSchema#string

John D McConnell

http://www.w3.org/2001/XMLSchema#string

John W Kusek

http://www.w3.org/2001/XMLSchema#string

Leroy M Nyberg

http://www.w3.org/2001/XMLSchema#string

Michael K Brawer

http://www.w3.org/2001/XMLSchema#string

Oliver M Bautista

http://www.w3.org/2001/XMLSchema#string

Raymond P Bain

http://www.w3.org/2001/XMLSchema#string

Stephen A Sihelnik

http://www.w3.org/2001/XMLSchema#string

P304

224-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0197-2456(02)00263-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12689743

http://www.w3.org/2001/XMLSchema#string